Patents by Inventor Kerry E. Quinn

Kerry E. Quinn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040086931
    Abstract: The present invention provides novel isolated MEMX polynucleotides and polypeptides encoded by the MEMX polynucleotides. Also provided are the antibodies that immunospecifically bind to a MEMX polypeptide or any derivative, variant, mutant or fragment of the MEMX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the MEMX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: November 3, 2003
    Publication date: May 6, 2004
    Inventors: Steven K. Spaderna, Kerry E. Quinn, Richard A. Shimkets, Muralidhara Padigaru, Kimberly A. Spytek
  • Publication number: 20030077697
    Abstract: The present invention provides a novel isolated SER5 polynucleotide and a polypeptide encoded by the SER5 polynucleotide. Also provided are the antibodies that immunospecifically bind to a SER5 polypeptide or any derivative, variant, mutant or fragment of the SER5 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the SER5 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states as well as other uses.
    Type: Application
    Filed: July 3, 2001
    Publication date: April 24, 2003
    Inventors: Valerie L. Gerlach, John R. MacDougall, Kerry E. Quinn, Kumud Majumder, Kimberly A. Spytek, Corine Vernet, Catherine E. Burgess, Elma R. Fernandes, Luca Rastelli, John L. Herrmann, Steven K. Spaderna, Richard A. Shimkets, Raymond J. Taupier
  • Publication number: 20030065140
    Abstract: Disclosed herein are novel human nucleic acid sequences which encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: April 3, 2001
    Publication date: April 3, 2003
    Inventors: Corine A.M. Vernet, Catherine E. Burgess, Elma R. Fernandes, Raymond J. Taupier, Kerry E. Quinn, Kimberly A. Spytek, Luca Rastelli, John L. Herrmann
  • Publication number: 20030032166
    Abstract: Disclosed are nucleic acids encoding aortic carboxypeptidase-related polypeptides, polypeptides encoded by these nucleic acids, and methods of using these nucleic acids and polypeptides.
    Type: Application
    Filed: November 28, 2001
    Publication date: February 13, 2003
    Inventors: Kerry E. Quinn, Carol E. A. Pena, Li Li, Steven K. Spaderna, Mario W. Leite
  • Patent number: 6420155
    Abstract: Disclosed are nucleic acids encoding aortic carboxypeptidase-related polypeptides, polypeptides encoded by these nucleic acids, and methods of using these nucleic acids and polypeptides.
    Type: Grant
    Filed: August 18, 2000
    Date of Patent: July 16, 2002
    Assignee: Curagen Corporation
    Inventor: Kerry E. Quinn
  • Publication number: 20020077466
    Abstract: The present invention provides novel isolated MEMX polynucleotides and polypeptides encoded by the MEMX polynucleotides. Also provided are the antibodies that immunospecifically bind to a MEMX polypeptide or any derivative, variant, mutant or fragment of the MEMX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the MEMX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: December 14, 2000
    Publication date: June 20, 2002
    Inventors: Steven K. Spaderna, Kerry E. Quinn, Richard A. Shimkets, Muralidhara Padigaru, Kimberly A. Spytek
  • Publication number: 20010046665
    Abstract: Disclosed is a method of identifying the function of a test compound by contacting a plurality of cells with the test compound. The plurality includes at least a first cell and a second cell of a different type than the first cell type. Expression of one or more genes in cells of the plurality is measured.
    Type: Application
    Filed: January 19, 2001
    Publication date: November 29, 2001
    Inventors: Thomas J. Powell, Stacey A. Minskoff, Kerry E. Quinn, Tennore M. Ramesh